Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
van Vollenhoven, Ronald [3 ]
Kavanaugh, Arthur [4 ]
Strand, Vibeke [5 ]
Vencovsky, Jiri [6 ]
Schiff, Michael H. [7 ]
Landewe, Robert [8 ,9 ]
Haraoui, Boulos [10 ]
Walker, Susan [11 ]
van der Heijde, Desiree [12 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Karolinska Inst, Stockholm, Sweden
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Stanford Univ, Palo Alto, CA 94304 USA
[6] Charles Univ Prague, Dept Clin & Expt Rheumatol, Inst Rheumatol, Fac Med 1, Prague, Czech Republic
[7] Univ Colorado, Denver, CO 80202 USA
[8] Acad Med Ctr Amsterdam, Heerlen, Netherlands
[9] Atrium Med Ctr, Heerlen, Netherlands
[10] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[11] UCB Pharma, Raleigh, NC USA
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2321
引用
收藏
页码：S988 / S989
页数：2
相关论文
共 50 条
  • [21] Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy On Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
    Strand, Vibeke
    Purcaru, Oana
    van Vollenhoven, Ronald F.
    Choy, Ernest
    Fleischmann, Roy
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S567 - S567
  • [22] Efficacy of long-term (104-week) treatment with apremilast in patients with psoriatic arthritis: Results from a phase III, randomized, controlled trial and open-label extension
    Edwards, Christopher
    Blanco, Francisco
    Crowley, Jeffrey
    Hu, Chia Chi
    Shah, Kamal
    Birbara, Charles
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [23] Long Term Tolerability and Efficacy of a 4-week-administration of Certolizumab pegol as Monotherapy and Combination Therapie in rheumatoid Arthritis-5-Year-Data of an open Extension Study
    Alten, R.
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 111 - 111
  • [24] Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease
    Moebius, HJ
    Reisberg, B
    Schmitt, F
    Doody, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S388 - S389
  • [25] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2020, 40 : 60 - 61
  • [26] Combination therapy with certolizumab pegol plus methotrexate maintains long-term efficacy in the treatment of rheumatoid arthritis: A 2-year analysis
    Keystone, Edward C.
    Schiff, Michael H.
    Mease, Philip
    van Vollenhoven, Ronald F.
    Desai, Chintu
    Smolen, Josef
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S529 - S529
  • [27] Combination Therapy with Certolizumab Pegol Plus Methotrexate Maintains Long-term Efficacy in the Treatment of Rheumatoid Arthritis: A 2-year Analysis
    Haraoui, Paul
    Keystone, Edward
    Schiff, Michael
    Mease, Philip
    van Vollenhoven, Ronald F.
    Desai, Chintu
    Smolen, Josef
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2572 - 2572
  • [28] Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: 52 Week Safety and Efficacy in an Open-Label, Long-Term Extension Study
    Baker, Milton
    Chalabi, Youb
    Genovese, Mark
    Taylor, Peter
    Schlichting, Douglas
    Beattie, Scott
    Macias, William
    Keystone, Edward
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1505 - 1505
  • [29] Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
    Bi, L.
    Li, Y.
    He, L.
    Xu, H.
    Jiang, Z.
    Wang, Y.
    Li, X.
    Wei, W.
    Gu, J.
    Wang, G.
    Zhang, Z.
    Zhou, B.
    Liu, Y.
    Wu, Z.
    Liu, H.
    He, D.
    Lv, Z.
    Li, Z.
    Zuo, X.
    Dong, L.
    Wu, H.
    Zhang, H.
    Chen, H.
    Bao, C.
    Zhang, Z.
    Zhang, M.
    Song, H.
    Zheng, Y.
    Jiang, L.
    Liu, X.
    Boehnlein, M.
    Dunkel, J.
    Shao, J.
    Harris, K.
    Li, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 227 - 234
  • [30] A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
    Emeryk, Andrzej
    Klink, Rabih
    McIver, Tammy
    Dalvi, Prashant
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (04) : 324 - 337
12345